APA (7th ed.) Citation

X, M., B, R., C, N., M, R., M, F., Y, W., & M, C. (2024). SCALA: A randomized phase I trial comparing subcutaneous and intravenous alemtuzumab in patients with progressive multiple sclerosis. Therapeutic advances in neurological disorders, 17, 17562864241291655. https://doi.org/10.1177/17562864241291655

Chicago Style (17th ed.) Citation

X, Montalban, Rodriguez-Acevedo B, Nos C, Resina M, Forner M, Wu Y, and Chirieac M. "SCALA: A Randomized Phase I Trial Comparing Subcutaneous and Intravenous Alemtuzumab in Patients with Progressive Multiple Sclerosis." Therapeutic Advances in Neurological Disorders 17 (2024): 17562864241291655. https://doi.org/10.1177/17562864241291655.

MLA (9th ed.) Citation

X, Montalban, et al. "SCALA: A Randomized Phase I Trial Comparing Subcutaneous and Intravenous Alemtuzumab in Patients with Progressive Multiple Sclerosis." Therapeutic Advances in Neurological Disorders, vol. 17, 2024, p. 17562864241291655, https://doi.org/10.1177/17562864241291655.